Arecor and JDRF joint research, development and commercialisation agreement. Arecor Ltd has signed a Research, Development and Commercialisation agreement with JDRF, the leading global organisation
In an article for the New York Times, Donald McNeil reported, “With insulin prices skyrocketing and substantial shortages developing in poorer countries, the World Health
New diabetes treatments can be hard to keep track of. Here we take a look at some of the newer treatments and trials for diabetes.
Eli Lilly has decided to terminate its partnership with Adocia for the development of BioChaperone Lispro, an ultra-rapid insulin for diabetes. Despite results from 6